GEMAROMA Q1 FY27 Guidance vs Delivery (GEMAROMA Management Mirror)

FY 28 Consolidated Revenue Guidance Reaffirmed at INR 1,050-1,100 Crores with 16-18% EBITDA Margins; Crystal Ingredients Mix to Exceed 50%

Management's long-term financial guidance has remained steady across the latest three quarters. In the Dec'25 Qtr concall, management projected FY 28 consolidated revenue of INR 1,050 crores to INR 1,100 crores, with EBITDA margins in the range of 16% to 18%. This was explicitly reaffirmed during the Mar'26 Qtr concall. By the Jun'26 Qtr, while specific FY 27 guidance remained withheld as a ramp-up year, management expanded on the FY 28 outlook, guiding that Crystal Ingredients products are expected to represent more than 50% of the overall consolidated revenue. Operating leverage is expected to support margins and profitability over the medium term as capacity utilization scales up.